LinkedIn Image Downloadable Slides From Examining Successes and Seeking New Strategies in Pediatric Acute Lymphoblastic Leukemia

Downloadable Slides From Examining Successes and Seeking New Strategies in Pediatric Acute Lymphoblastic Leukemia

View Activity

Activity Features

Downloadable Slides

Activity Overview

If you missed our pediatric lymphoblastic leukemia symposium in Jerusalem, download the meeting slides and see what our expert faculty covered at Examining Successes and Seeking New Strategies in Pediatric Acute Lymphoblastic Leukemia held in conjunction with the 28th Annual Meeting of the International BFM Study Group.

Provider

This activity is provided by prIME Oncology.

Supporter

This educational activity is supported by a grant from Shire.

Featured Expert

  • Ajay Vora, MD, FRCP, FRCPath, Great Ormond Street Hospital, London, United Kingdom
    University of Sheffield, Sheffield, United Kingdom

Featured Topic

There is only one first time: Making the most of initial therapy for pediatric ALL

Learning Objective

  • Select an appropriate first-line treatment strategy for pediatric patients with ALL based on recent clinical trial data and expert recommendations, including considerations for “pediatric-inspired” therapy for adolescent patients.

Featured Expert

  • Martin Schrappe, MD, PhD, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany

Featured Topic

How do you measure success in ALL?: Assessment of MRD

Learning Objective

  • Describe the importance of eliminating minimal residual disease and the role it plays in treatment selection throughout the management of ALL.

Featured Expert

  • Shai Izraeli, MD, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel

Featured Topic

Strategic decisions for relapsed ALL: How and when to incorporate novel agents

Learning Objective

  • Identify an effective treatment approach for patients with relapsed/refractory ALL, including considerations for reinduction, prognostic factors, and incorporation of emerging therapies.

Featured Expert

  • Shai Izraeli, MD, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel

Featured Topic

Conclusion and prIME Points